Andrea E DeBarber

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. pmc Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, USA
    J Chromatogr A 1210:55-9. 2008
  2. pmc Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, United States
    J Chromatogr B Analyt Technol Biomed Life Sci 879:1384-92. 2011
  3. ncbi request reprint A useful multi-analyte blood test for cerebrotendinous xanthomatosis
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University OHSU, Portland, OR 97239, USA Electronic address
    Clin Biochem 47:860-3. 2014
  4. pmc Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, USA
    Anal Biochem 381:151-3. 2008
  5. doi request reprint ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, USA
    Clin Chim Acta 411:43-8. 2010
  6. doi request reprint A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR
    J Lipid Res 55:146-54. 2014
  7. pmc Smith-Lemli-Opitz syndrome
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR, USA
    Expert Rev Mol Med 13:e24. 2011
  8. pmc Smith-Lemli-Opitz syndrome and inborn errors of cholesterol synthesis: summary of the 2007 SLO/RSH Foundation scientific conference sponsored by the National Institutes of Health
    Louise S Merkens
    Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239, USA
    Genet Med 11:359-64. 2009

Detail Information

Publications8

  1. pmc Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, USA
    J Chromatogr A 1210:55-9. 2008
    ..2 mL) at the method limit of detection. In summary, the LC-MS/MS method enables quantification of circulating 3-iodothyronamine to allow examination of a relationship with biological activity...
  2. pmc Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, United States
    J Chromatogr B Analyt Technol Biomed Life Sci 879:1384-92. 2011
    ....
  3. ncbi request reprint A useful multi-analyte blood test for cerebrotendinous xanthomatosis
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University OHSU, Portland, OR 97239, USA Electronic address
    Clin Biochem 47:860-3. 2014
    ..0mg/dl)...
  4. pmc Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, USA
    Anal Biochem 381:151-3. 2008
    ..The availability of an LC-MS method offers advantages such as simplified sample work-up and analysis...
  5. doi request reprint ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR 97239, USA
    Clin Chim Acta 411:43-8. 2010
    ..The method routinely used to screen for CTX is GC-based measurement of elevated 5alpha-cholestanol from hydrolyzed plasma. A plasma test for CTX utilizing ESI-MS/MS methodology would be beneficial...
  6. doi request reprint A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR
    J Lipid Res 55:146-54. 2014
    ..Early detection and intervention through newborn screening would greatly benefit those affected with CTX by preventing morbidity and mortality. ..
  7. pmc Smith-Lemli-Opitz syndrome
    Andrea E DeBarber
    Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR, USA
    Expert Rev Mol Med 13:e24. 2011
    ..Additional research in these and other areas is critical if we are to make headway towards ameliorating the effects of this devastating condition...
  8. pmc Smith-Lemli-Opitz syndrome and inborn errors of cholesterol synthesis: summary of the 2007 SLO/RSH Foundation scientific conference sponsored by the National Institutes of Health
    Louise S Merkens
    Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239, USA
    Genet Med 11:359-64. 2009
    ....